Internal Medicine, Clinical Cardiatric Electrophysiology · San Jose, CA
NPI
1649334079
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
2581 Samaritan Drive, Suite 202
San Jose, CA, 95124
Phone (408) 358-3939
Groups this clinician bills Medicare through
Medicare paid, 2024
$462K
6,125 services
Medicare patients, 2024
1,033
Average age 79
Drug cost, 2024
$742K
2,139 prescriptions
Company payments, 2025
$9,599
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew T Levy was code 93298 (external electrocardiographic monitoring), 1,334 times for 159 patients. In total Matthew T Levy billed 6,125 services in 64 codes, and Medicare paid $462K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93298 External Electrocardiographic Monitoring | Office | 1,334 | 159 | $75.59 | $101K |
| 93294 External Electrocardiographic Monitoring | Office | 766 | 255 | $23.32 | $18K |
| 93296 External Electrocardiographic Monitoring | Office | 766 | 260 | $21.27 | $16K |
| 93297 External Electrocardiographic Monitoring | Office | 676 | 95 | $57.85 | $39K |
| 93000 Electrocardiogram | Office | 524 | 382 | $13.34 | $6,992 |
| 99213 Office E&M - Established | Office | 311 | 281 | $79.71 | $25K |
| 99214 Office E&M - Established | Office | 227 | 181 | $116.39 | $26K |
| 93280 External Electrocardiographic Monitoring | Office | 211 | 177 | $39.51 | $8,337 |
| 99215 Office E&M - Established | Office | 101 | 93 | $162.44 | $16K |
| 99205 Office E&M - New | Office | 85 | 85 | $199.22 | $17K |
| 93306 Echocardiography (TTE/TEE) | Office | 73 | 73 | $177.86 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 67 | 36 | $105.04 | $7,037 |
| 99204 Office E&M - New | Office | 63 | 63 | $151.51 | $9,545 |
| 93623 Comprehensive Electrophysiologic Evaluation | Facility | 62 | 59 | $60.70 | $3,763 |
| 93312 Echocardiography (TTE/TEE) | Facility | 59 | 51 | $94.53 | $5,577 |
By year: 2022 $435K for 6,889 services; 2023 $466K for 6,776 services; 2024 $462K for 6,125 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew T Levy prescribed most often to Medicare patients was Eliquis (Apixaban), with 355 prescriptions and refills. In total Matthew T Levy wrote 2,139 Medicare prescriptions that cost $742K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 355 | 828 | 105 | $475K |
| Flecainide Acetate Generic | 330 | 898 | 100 | $16K |
| Metoprolol Succinate Generic | 293 | 789 | 87 | $5,042 |
| Xarelto Rivaroxaban | 156 | 352 | 38 | $194K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 137 | 351 | 45 | $5,131 |
| Amiodarone Hcl Generic | 100 | 241 | 41 | $1,978 |
| Sotalol Af Sotalol Hcl | 94 | 253 | 35 | $3,570 |
| Sotalol Sotalol Hcl | 94 | 274 | 30 | $1,804 |
| Metoprolol Tartrate Generic | 83 | 226 | 37 | $821 |
| Cephalexin Generic | 82 | 82 | 78 | $345 |
| Amlodipine Besylate Generic | 56 | 149 | 19 | $448 |
| Furosemide Generic | 50 | 122 | 21 | $477 |
| Potassium Chloride Generic | 33 | 81 | 11 | $1,129 |
| Digoxin Generic | 28 | 80 | Under 11 | $793 |
| Lisinopril Generic | 26 | 72 | Under 11 | $525 |
Brand drugs: 541 claims; generic drugs: 1,598 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew T Levy $9,599 ($9,599 in general payments such as food, travel and fees) from 2 companies. The largest payer was Biotronik Inc. with $9,576.
| Company | Payments | Amount |
|---|---|---|
| Biotronik Inc. | 24 | $9,576 |
| Abbott Laboratories ABT | 1 | $22.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.